urine collection

PreclinicalBiologic

CCHU de Reims

urine collection is one of 76 biologic programs targeting Chronic Kidney Disease. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Chronic Kidney DiseaseActive, not recruiting

Elderly PatientsCompleted

MPRRecruiting

Chronic Kidney DiseasePreclinical

Active, not recruiting

Elderly PatientsPreclinical

Completed

MPRPreclinical

Recruiting

Competition

Competitive Landscape

172 competitors in Chronic Kidney Disease

#DrugCompanyPhaseTrials

Effcamgcit

UUniversity of Texas Southwestern Medical Center

Phase 3

1 2

Uloric

Takeda

Preclinical

2 3

Sovaldi

Gilead

Preclinical

1 4

Glucotrol

Pfizer

Preclinical

1 5

Vemlidy

Gilead

Preclinical

1 6

Lorelco

Sanofi

Preclinical

1 7

Activase

Flomax

Verquvo

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Preclinical

1 10

PROCRIT

WWim Janssens

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2037

N/ARecruiting

MPR

NCT06355713

Clinical

Trials by Indication[1]

Chronic Kidney Disease1 trial

Impact of Obesity, Chronic Kidney Disease and Type 2 Diabetes on Human Urinary Stem Cells

Not yet recruiting·HHospices Civils de Lyon··NCT04998461·60 enrolled

MPR1 trial

Improvement of Symptoms After Removal of the Essure® Contraceptive Implant

Recruiting·HHospices Civils de Lyon·N/A·NCT06355713·444 enrolled

Intravenous1 trial

Incidence, Risk Factors and Impact on Renal Function of the Appearance of Crystalluria Under High-dose Intravenous Amoxicillin

Completed·CCHU de Reims··NCT02853292·153 enrolled

Elderly Patients1 trial

Fragmentation of Elastin as a Biological Marker of Frailty and Impact in Tumor Progression in Elderly Patients With Cancer

Completed·CCHU de Reims·N/A·NCT02807129·296 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for urine collection. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — urine collection compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for urine collection. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — CHU de Reims company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: CCHU de Reims

urine collection

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2037

Trials by Indication[1]

Chronic Kidney Disease1 trial

MPR1 trial

Intravenous1 trial

Elderly Patients1 trial

References

Drug Info

Quick Facts

Related News